The Singota Story
Singota Solutions was founded in 2006 as BioConvergence LLC. Alisa Kilgas, the CEO and founder, envisioned a CDMO that would fill the gaps in the drug development process and focus on getting patients the treatments they need faster.
As the company continued to grow, so did the needs of its clients. In 2016, BioConvergence announced it would expand its services with the addition of aseptic manufacturing and rebrand as Singota Solutions. Singota Solutions now offers and specializes in small batch aseptic filler, aseptic manufacturing solutions, and injectable formulation development.
Since rebranding, Singota Solutions has broadened its Supply Chain (complete with cold chain pharmaceutical storage and gmp compliant warehouse facilities) from Domestic to International, now extending its capabilities into Europe. Singota’s agile and rapid approach to drug and formulation development remains exemplary, showcasing their commitment to advancing client projects through the drug pipeline swiftly. As they continue to expand their expertise, Singota is poised to facilitate even faster navigation of the drug development process for their clients.